Invention Grant
- Patent Title: Tranexamic acid oral solution
-
Application No.: US16243234Application Date: 2019-01-09
-
Publication No.: US11666532B2Publication Date: 2023-06-06
- Inventor: Mary Beth G. Erstad , Thomas Gerner Jacobsen , Mohammad Alkhalili , L. Diane Bruce , Paul Hafey
- Applicant: Hyloris Developments SA
- Applicant Address: BE Liège
- Assignee: Hyloris Developments SA
- Current Assignee: Hyloris Developments SA
- Current Assignee Address: BE Liege
- Agency: Neal, Gerber & Eisenberg LLP
- Main IPC: A61K9/08
- IPC: A61K9/08 ; A61K31/195 ; A61K47/10 ; A61K47/14 ; A61K47/26 ; A61K47/38 ; A61K9/00 ; A61P7/04

Abstract:
Methods and compositions are provided for treating a patient having a bleeding disorder during or after a dental procedure to reduce bleeding or need for factor replacement therapy. Aqueous pharmaceutical compositions are provided comprising tranexamic acid, sodium carboxymethyl cellulose, Tween® 20, and menthol wherein the composition exhibits good long term stability, little to no discoloration over time, and reduced bitterness compared to a control solution of tranexamic acid and water.
Public/Granted literature
- US20190224121A1 TRANEXAMIC ACID ORAL SOLUTION Public/Granted day:2019-07-25
Information query